Domů › Rakovina prsu › Distrikt Kolumbie › Washington
Klinické studie Rakovina prsu v Washington, DC
46 studií pro Rakovina prsu hledá účastníky v lokalitách v Washington a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Probíhá náborFáze 3
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Probíhá náborFáze 3
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · Vzdálenost 7 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
Genomic Services Research Program
Probíhá náborObservační studie
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Older Breast Cancer Patients: Risk for Cognitive Decline
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Probíhá náborFáze 2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Probíhá náborFáze 3
- Holy Cross Hospital ( Site 0073), Silver Spring · Vzdálenost 7 mi
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Probíhá náborFáze 2
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Probíhá náborFáze 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · Vzdálenost 7 mi
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Probíhá náborFáze 3
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · Vzdálenost 6 mi
Identifying Patterns in the Breath of Individuals With Breast Cancer
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Probíhá náborFáze 3
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- a dalších 1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Probíhá náborFáze 1
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Probíhá náborFáze 1/2
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Probíhá náborFáze 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · Vzdálenost 7 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Probíhá náborFáze 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- a dalších 5
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Probíhá náborFáze 2
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Probíhá nábor
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
Probíhá nábor
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Probíhá náborFáze 3
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Probíhá náborFáze 1/2
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Probíhá nábor
- Walter Reed National Military Medical Center, Bethesda · Vzdálenost 7 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Probíhá náborFáze 3
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
Probíhá náborFáze 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- a dalších 2
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- National Institutes of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Probíhá náborFáze 2
- National Institute of Health Clinical Center, Bethesda · Vzdálenost 7 mi
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Probíhá náborFáze 3
- American Oncology Partners, P.A., Bethesda · Vzdálenost 7 mi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Probíhá náborFáze 2
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Probíhá náborFáze 3
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · Vzdálenost 7 mi
- Maryland Oncology Hematology P.A., Bethesda · Vzdálenost 7 mi
- a dalších 1
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Probíhá náborFáze 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- a dalších 2
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Probíhá náborFáze 2
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Probíhá náborFáze 2
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
Probíhá nábor
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Probíhá náborObservační studie
- Holy Cross Hospital - Silver Spring, Silver Spring · Vzdálenost 7 mi
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · Vzdálenost 7 mi
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Probíhá náborObservační studie
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Silver Spring · Vzdálenost 7 mi
- Massive Bio SYNERGY-AI site, Bethesda · Vzdálenost 7 mi
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Probíhá nábor
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Probíhá náborVítáni zdraví dobrovolníci
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Probíhá náborObservační studie
- Maryland Oncology Hematology, PA, Silver Spring · Vzdálenost 7 mi
- Maryland Oncology Hematology - Bethesda, Bethesda · Vzdálenost 7 mi
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Probíhá náborObservační studie
- George Washington University, Washington D.C.
Studie Rakovina prsu v jiných městech
- New York City, NY136 studií
- Houston, TX126 studií
- Boston, MA112 studií
- Nashville, TN81 studií
- Los Angeles, CA73 studií
- Edison, NJ68 studií
- St. Louis, MO64 studií
- Queens, NY64 studií
- Durham, NC64 studií
- Chicago, IL59 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
Další studie v Washington
- Rakovina (všechny typy)58 studií
- Nemalobuněčný plicní karcinom55 studií
- Metastatický karcinom43 studií
- Rakovina plic41 studií
- Rakovina prostaty38 studií
- Obesity33 studií
- Kolorektální karcinom29 studií
- Kardiovaskulární onemocnění28 studií
- Rakovina močového měchýře26 studií
- Akutní myeloidní leukemie24 studií
- Rakovina vaječníků23 studií
- Lymfom23 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.